Rossari Biotech Ltd9:48 pm IST
Rossari Biotech Q1 FY27 revenue 697 cr; Thailand facility and asset monetisation underway
Business Overview
- Rossari Biotech is a specialty chemicals manufacturer with HPPC, Textile, and AHN segments.
- Strategic focus on portfolio rationalisation and international expansion.
- Thailand blending facility established; capacity 5,000 MTPA.
- Monetisation of non-core assets progressing: Andheri office sale; Kanjurmarg sale earlier.
Key Operational Highlights
- Q1 FY27 revenue 697.2 cr; EBITDA 80.6 cr; PAT 35.1 cr.
- HPPC, TSC, AHN grew YoY by 28%, 28%, 27%.
- Consolidated revenue growth 28.2% YoY; margins around 11-14% across segments.
- Expanded international footprint with Thailand blending facility to serve SE Asia.
- Sale of Andheri office completed; progress on non-core asset monetisation.
Financial Performance
- Revenue from operations: 697.2 cr in Q1 FY27; +28.2% YoY.
- EBITDA 80.6 cr; EBITDA margin 11.6%.
- PAT 35.1 cr; PAT margin 5.0%.
- FY26 four-year trend: revenue 2,396 cr; EBITDA 286 cr; PAT 149 cr.
- Healthy balance sheet and liquidity support growth.
Capital Structure & Liquidity
- Zero-debt status since 2020-21.
- Monetisation of non-core assets improving liquidity.
- Capex: additional 50,000 MTPA EO derivatives capacity expansion.
- International expansion in DMCC, Jafza, Thailand, KSA, Singapore.
Strategic Priorities & Outlook
- Grow core HPPC, TSC, AHN via cross-sell and new applications.
- Invest in product development; strengthen R&D pipeline.
- Strengthen manufacturing footprint via brownfield capacities; evaluate KSA greenfield.
- Expand international distribution and partnerships; disciplined capital allocation.
- Thailand facility enhances SE Asia footprint; supply chain resilience.
- FY27: disciplined execution and profitable growth.
Governance & Leadership
- Appointment of Udeypaul Singh Gill as director; effective 28.04.2026.
- Independent directors on board; founders/promoters active in leadership.
- Subsidiaries expansion: DMCC, Jafza, Thailand, KSA, Singapore.